Cargando…

Large Extracellular Vesicles—A New Frontier of Liquid Biopsy in Oncology

Extracellular Vesicles (EVs) are emerging as pivotal elements in cancer. Many studies have focused on the role of Small- (S)-EVs but in recent years Large-(L)-EVs have progressively gained increasing interest due to their peculiar content and functions. Tumor-derived L-EVs carry a lot of oncogenic p...

Descripción completa

Detalles Bibliográficos
Autores principales:	Pezzicoli, Gaetano, Tucci, Marco, Lovero, Domenica, Silvestris, Franco, Porta, Camillo, Mannavola, Francesco
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	MDPI 2020
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7555129/ https://www.ncbi.nlm.nih.gov/pubmed/32906787 http://dx.doi.org/10.3390/ijms21186543

Ejemplares similares

Liquid Biopsy as a Tool Exploring in Real-Time Both Genomic Perturbation and Resistance to EGFR Antagonists in Colorectal Cancer
por: Internò, Valeria, et al.
Publicado: (2020)

Liquid biopsy of cancer: a multimodal diagnostic tool in clinical oncology
por: Palmirotta, Raffaele, et al.
Publicado: (2018)

Liquid Biopsy in Cervical Cancer: Hopes and Pitfalls
por: Cafforio, Paola, et al.
Publicado: (2021)

Extracellular Vesicles and Epigenetic Modifications Are Hallmarks of Melanoma Progression
por: Mannavola, Francesco, et al.
Publicado: (2019)

Dual-procedural separation of CTCs in cutaneous melanoma provides useful information for both molecular diagnosis and prognosis
por: Tucci, Marco, et al.
Publicado: (2020)

Extracellular Vesicles from Thyroid Carcinoma: The New Frontier of Liquid Biopsy
por: Rappa, Germana, et al.
Publicado: (2019)

Extracellular vesicle-based liquid biopsy biomarkers and their application in precision immuno-oncology
por: Asleh, Karama, et al.
Publicado: (2023)

Application of “omics” sciences to the prediction of bone metastases from breast cancer: State of the art
por: Gentile, Marica, et al.
Publicado: (2020)

Extracellular Vesicles and the Promise of Continuous Liquid Biopsies
por: Armstrong, Don, et al.
Publicado: (2018)

Circulating tumor cells and extracellular vesicles as liquid biopsy markers in neuro-oncology: prospects and limitations
por: Westphal,, Manfred, et al.
Publicado: (2022)

Noncoding RNAs in Extracellular Fluids as Cancer Biomarkers: The New Frontier of Liquid Biopsies
por: Pardini, Barbara, et al.
Publicado: (2019)

Extracellular Vesicles in Liquid Biopsies: Potential for Disease Diagnosis
por: Liu, Jialing, et al.
Publicado: (2021)

Advanced Nanotechnologies for Extracellular Vesicle‐Based Liquid Biopsy
por: Min, Li, et al.
Publicado: (2021)

Extracellular Vesicles in Liquid Biopsies as Biomarkers for Solid Tumors
por: Irmer, Barnabas, et al.
Publicado: (2023)

Combination of immunotherapy and other targeted therapies in advanced cutaneous melanoma
por: Marconcini, Riccardo, et al.
Publicado: (2021)

Beyond RAS and BRAF: HER2, a New Actionable Oncotarget in Advanced Colorectal Cancer
por: Guarini, Chiara, et al.
Publicado: (2021)

The ATM Gene in Breast Cancer: Its Relevance in Clinical Practice
por: Stucci, Luigia Stefania, et al.
Publicado: (2021)

Circulating tumor cells from melanoma patients show phenotypic plasticity and metastatic potential in xenograft NOD.CB17 mice
por: Felici, Claudia, et al.
Publicado: (2022)

The coming of age of liquid biopsy in neuro-oncology
por: Berzero, Giulia, et al.
Publicado: (2023)

Clinical relevance of extracellular vesicles in hematological neoplasms: from liquid biopsy to cell biopsy
por: Trino, Stefania, et al.
Publicado: (2020)

SNPs in predicting clinical efficacy and toxicity of chemotherapy: walking through the quicksand
por: Palmirotta, Raffaele, et al.
Publicado: (2018)

Liquid biopsy using extracellular vesicle–derived DNA in lung adenocarcinoma
por: Kim, In Ae, et al.
Publicado: (2020)

Emerging methods in biomarker identification for extracellular vesicle‐based liquid biopsy
por: Liang, Yaxuan, et al.
Publicado: (2021)

Exosomes in melanoma: a role in tumor progression, metastasis and impaired immune system activity
por: Tucci, Marco, et al.
Publicado: (2018)

Exosomes as a new frontier of cancer liquid biopsy
por: Yu, Dan, et al.
Publicado: (2022)

Circulating dendritic cell levels identify high-risk stage II-III melanoma patients: a potential role as additional prognostic marker
por: Stucci, Stefania, et al.
Publicado: (2015)

Immune system and melanoma biology: a balance between immunosurveillance and immune escape
por: Passarelli, Anna, et al.
Publicado: (2017)

An Emerging Frontier in Intercellular Communication: Extracellular Vesicles in Regeneration
por: Avalos, Priscilla N., et al.
Publicado: (2022)

Extracellular Vesicles: A New Frontier for Cardiac Repair
por: You, Benshuai, et al.
Publicado: (2022)

Ultra-sensitive liquid biopsy of circulating extracellular vesicles using ExoScreen
por: Yoshioka, Yusuke, et al.
Publicado: (2014)

Fibronectin on circulating extracellular vesicles as a liquid biopsy to detect breast cancer
por: Moon, Pyong-Gon, et al.
Publicado: (2016)

Application of Microfluidic Chips in Separation and Analysis of Extracellular Vesicles in Liquid Biopsy for Cancer
por: Lu, Jin, et al.
Publicado: (2019)

Rapid Detection and Trapping of Extracellular Vesicles by Electrokinetic Concentration for Liquid Biopsy on Chip
por: Cheung, Lucia S., et al.
Publicado: (2018)

DNA-Loaded Extracellular Vesicles in Liquid Biopsy: Tiny Players With Big Potential?
por: García-Silva, Susana, et al.
Publicado: (2021)

The Potential Application of Extracellular Vesicles from Liquid Biopsies for Determination of Pharmacogene Expression
por: Habtemariam, Henok D., et al.
Publicado: (2022)

Extracellular Vesicles and Circulating Tumour Cells - complementary liquid biopsies or standalone concepts?
por: Słomka, Artur, et al.
Publicado: (2022)

Extracellular vesicle-based liquid biopsies in cancer: Future biomarkers for oral cancer
por: Minami, Sakura, et al.
Publicado: (2023)

Extracellular Vesicle-DNA: The Next Liquid Biopsy Biomarker for Early Cancer Diagnosis?
por: Tatischeff, Irène
Publicado: (2023)

Playing the Devil’s Advocate: Should We Give a Second Chance to mTOR Inhibition in Renal Clear Cell Carcinoma? – ie Strategies to Revert Resistance to mTOR Inhibitors
por: Pezzicoli, Gaetano, et al.
Publicado: (2021)

A Glimpse in the Future of Malignant Mesothelioma Treatment
por: Pezzicoli, Gaetano, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_6pnvufva9lvjh6ph015e3in9bb